1 research outputs found
Removing Barriers to Tecovirimat for Mpox-infected Individuals via Novel Models of Care Delivery
Problem Statement
During the 2022 mpox outbreak, the CDC’s expanded access Investigational New Drug (IND) protocol created a practical barrier to the outpatient provision of tecovirimat. We rapidly implemented a tecovirimat prescription program for individuals infected with mpox to improves access to care.
Project AIM
Primary aim: describe how we rapidly implemented a program for increasing tecovirimat distribution in a metropolitan area.
Secondary aims: describe the patient population who received tecovirimat as treatment for mpox at our clinic and analyze several clinically relevant time intervals along the continuum of care delivery.https://jdc.jefferson.edu/didemposters/1004/thumbnail.jp